Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2025)
Historic Gains from Investment Securities for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $24.8 million.
- Twist Bioscience's Gains from Investment Securities rose 685870.79% to $24.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.2 million, marking a year-over-year increase of 15018.75%. This contributed to the annual value of -$2.2 million for FY2025, which is 9509.68% up from last year.
- Per Twist Bioscience's latest filing, its Gains from Investment Securities stood at $24.8 million for Q4 2025, which was up 685870.79% from -$240000.0 recorded in Q3 2025.
- Twist Bioscience's Gains from Investment Securities' 5-year high stood at $33.5 million during Q2 2021, with a 5-year trough of -$44.1 million in Q2 2024.
- Its 5-year average for Gains from Investment Securities is $1.5 million, with a median of -$240000.0 in 2025.
- Per our database at Business Quant, Twist Bioscience's Gains from Investment Securities soared by 15108333.33% in 2022 and then crashed by 91413.02% in 2024.
- Quarter analysis of 5 years shows Twist Bioscience's Gains from Investment Securities stood at $10.4 million in 2021, then crashed by 104.79% to -$499000.0 in 2022, then soared by 37.47% to -$312000.0 in 2023, then soared by 214.1% to $356000.0 in 2024, then surged by 6858.71% to $24.8 million in 2025.
- Its last three reported values are $24.8 million in Q4 2025, -$240000.0 for Q3 2025, and -$1.2 million during Q2 2025.